A
Ascentage Pharma Group International
Q2 2025 earnings expected
Quarter
Apr – Jun
Expected
August 14, 2025(ET)
Revenue
This quarter$33M
Analyst estimate$33M▲ +0.0%
Year ago (Jun '24)$113M▼ -71.2%
EPS
Turned to a loss
This quarter-$0.96
Analyst estimate$0.00
Year ago (Jun '24)$0.30
Revenue Growth Trajectory
+122%YoY
Last 6 quarters · 1 analysts